Amalgamated Bank’s Alder Biopharmaceuticals ALDR Stock Holding History

Amalgamated Bank’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-12,960	Closed	-$244K	–	1861
2019 Q3	$244K	Sell	12,960 -127	-1%	-$1.45K	0.01%	1442
2019 Q2	$154K	Buy	+13,087	New	+$158K	﹤0.01%	1636

Amalgamated Bank's ALDR Position: Q4 2019 in Review

Amalgamated Bank sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 12,960 shares — an estimated $244K sold.

Amalgamated Bank first reported a position in ALDR in Q2 2019 and held it in 2 quarters. The position peaked at $244K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Amalgamated Bank reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Amalgamated Bank sold 12,960 Alder Biopharmaceuticals shares in Q4 2019, an estimated $244K.
Amalgamated Bank first reported a position in Alder Biopharmaceuticals in Q2 2019 and held it in 2 quarters.
Amalgamated Bank's Alder Biopharmaceuticals position peaked at $244K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Amalgamated Bank's 13F filing for Q4 2019, filed 13 Feb 2020.